Elizabeth Yeu Lin
Chief Medical Officer · Tarsus Pharmaceuticals, Inc.
- 2024
- Sep 9, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Elizabeth Yeu Lin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bobak R. Azamian - $4.69M in TARS purchases and sales in the last 12 months
- William J. Phd Link - $2.62M in TARS purchases and sales in the last 12 months
- Seshadri Neervannan - $2.00M in TARS purchases and sales in the last 12 months
- Jeffrey S. Farrow - $1.32M in TARS purchases and sales in the last 12 months
- Aziz Mottiwala - $893K in TARS purchases and sales in the last 12 months
- Bryan Wahl - $850K in TARS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Elizabeth Yeu Lin?
Elizabeth Yeu Lin is a corporate insider, tracked as Chief Medical Officer of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Elizabeth Yeu Lin submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Elizabeth Yeu Lin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($2.20M) across all tracked filings.
